1.
Els Lierman, Idoya Lahortiga, Helen Van Miegroet, Nicole Mentens, Peter Marynen, Jan Cools. The ability of sorafenib to inhibit oncogenic PDGFRβ and FLT3 mutants and overcome resistance to other small molecule inhibitors. haematol [Internet]. 2007Jan.1 [cited 2021Jul.26];92(1):27-4. Available from: https://haematologica.org/article/view/4301